Return to ZOOM MAP - Expand Steps to Minimize Opioid Use During Pregnancy or Pregnancy during Opioid Use

Background

One of the biggest challenges of addressing NAS is that is is not consistently identified, and collection of data and reporting is inconsistent.

Defining Neonatal Abstinence Syndrome

Indiana State Department of Health

In 2014, because of the high rate of opioid prescriptions, the Indiana General Assembly charged the Indiana State Department of Health (ISDH) to: develop a standard clinical definition of NAS and a standardized process of identifying it, identify the resources hospitals need to do this, and then establish a voluntary pilot program with hospitals to implement this standardized NAS identification. As of 2016, 26 of 89 Indiana Birthing Hospitals are taking part in this pilot screening program . ISDH noted that universal screening in a non-punitive environment would allow us to understand the true prevalence of Perinatal Substance Use and NAS.^[1]

The Indiana State Department of Health (ISDH) established a Task Force which defined a standard clinical definition of Neonatal Abstinence Syndrome
nas.PNG

The infant must:
Be symptomatic
Have two or three consecutive modified Finnegan scores equal to or greater than a total of 24
And have one of the following:
- A positive toxicology test OR
- A maternal history with a positive verbal screen or toxicology test

ISDH NAS Task Force Final Report:

[File:http://www.wikispaces.com/i/mime/32/application/pdf.png Neonatal_Abstinence_Syndrome_Report_Final_Report.pdf]

Neonatal_Abstinence_Syndrome_Report_Final_Report.pdf